Interleukin-15 response signature predicts RhCMV/SIV vaccine efficacy.
Saved in:
| Title: | Interleukin-15 response signature predicts RhCMV/SIV vaccine efficacy. |
|---|---|
| Authors: | Barrenäs, Fredrik1 (AUTHOR), Hansen, Scott G.2 (AUTHOR), Law, Lynn3 (AUTHOR), Driscoll, Connor3 (AUTHOR), Green, Richard R.3 (AUTHOR), Smith, Elise3 (AUTHOR), Chang, Jean3 (AUTHOR), Golez, Inah3 (AUTHOR), Urion, Taryn3 (AUTHOR), Peng, Xinxia4 (AUTHOR), Whitmore, Leanne3 (AUTHOR), Newhouse, Daniel3 (AUTHOR), Hughes, Colette M.2 (AUTHOR), Morrow, David2 (AUTHOR), Randall, Kurt T.2 (AUTHOR), Selseth, Andrea N.2 (AUTHOR), Ford, Julia C.2 (AUTHOR), Gilbride, Roxanne M.2 (AUTHOR), Randall, Bryan E.2 (AUTHOR), Ainslie, Emily2 (AUTHOR) |
| Source: | PLoS Pathogens. 7/6/2021, Vol. 17 Issue 7, p1-28. 28p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
